Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In

For nearly 40 years, labs across the globe have utilized Capture® technology.


Capture Workstation

Immucor’s Capture-R product line offers detection of unexpected red blood cell antibodies. Capture’s IgG specific technology provides high sensitivity for clinically significant antibodies, without the noise of IgM antibodies. To improve efficiency, reagent red blood cells are bound to test wells at the time​ of manufacture so there are no liquid reagent red blood cells to manage.

Testing on the Capture Workstation offers additional features including the option to extend incubation time up to 60 minutes, the upper limit for antibody detection, as well as additional testing options with Capture-R® Select.

Benefits of Capture Technology: ​​​​

Ease of Use

  • Ready to use reagents
  • Antigens are pre-coated on microwells
  • No special pipettes or precision pipetting
  • Consistent procedures across assays
  • Long shelf life for better inventory management

Performance & Productivity

  • IgG specific technology
  • High sensitivity for clinically significant RBC antibodies – compares to enzyme methods without the added work
  • Multiple assays for red blood cells, platelet and CMV
  • Comprehensive and broad automated test menu with quick turnaround times and high throughput


  • A wash step allows for the use of slightly lipemic or hemolyzed samples
  • Reports describe the use of Immucor products to help mitigate interference with monoclonal antibody therapies1,2
  • Run single sample or a full batch

Consistent and Accurate Manufacturing:

  • Immucor has a rich supply of donors. Our database of over 10,000 typed donors is utilized to create the best antigen profile on every lot.
  • Our donors are phenotyped by two separate laboratories using unique reagents.
  • We apply our experience with molecular immunohematology (MIH) to enhance the value of our serological products. Each donor’s full antigen profile, including extended antigen typing by DNA analysis is provided on the Supplemental Unit Typings (SUT) with each antibody identification panel.

*Product offerings may differ by region, please check with your local Immucor representative for regulatory status in your area. ​​​​​​​​​​​​​​​

1. Howard-Menk C, Crane JE, Doshi L, Papari M. HU5F9-G4 Monoclonal Anti-CD47 Therapy: A First Experience with Interference in Antibody Identification. Transfusion 2018; 58 [S2]:177A. ​​​​​​​​​​​​​​​

2. De Vooght KMK, Lozano M, Bueno JL, et al. Vox Sanguinis International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy: summary. Vox Sanguinis 2018; 113:492-498.

​​​​​​ ​​​​​
Related Products
​​​​ ​​​​​​